397 related articles for article (PubMed ID: 26592458)
21. Inhibition of platelet aggregation and blood coagulation by a P-III class metalloproteinase purified from Naja atra venom.
Sun QY; Wang CE; Li YN; Bao J
Toxicon; 2020 Nov; 187():223-231. PubMed ID: 32971099
[TBL] [Abstract][Full Text] [Related]
22. [Cardiovascular alterations induced by the venom of Lachesis muta (serpentes: Viperidae) and its fibrinogenolitic enzyme].
Granados-Zúñiga J; Aragón-Ortíz F
Rev Biol Trop; 1998 Dec; 46(4):1149-57. PubMed ID: 10751938
[TBL] [Abstract][Full Text] [Related]
23. Does size matter? Venom proteomic and functional comparison between night adder species (Viperidae: Causus) with short and long venom glands.
Coimbra FCP; Dobson J; Zdenek CN; Op den Brouw B; Hamilton B; Debono J; Masci P; Frank N; Ge L; Kwok HF; Fry BG
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Sep; 211():7-14. PubMed ID: 29758383
[TBL] [Abstract][Full Text] [Related]
24. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
25. A case report of Ovophis monitcola (Mountain pit-viper) envenoming in northeastern India resulting in prolonged coagulopathy.
Ralph R; Garg D; Balachandran A; Ganesh SR; Lamb T
Toxicon; 2023 Jun; 229():107147. PubMed ID: 37127123
[TBL] [Abstract][Full Text] [Related]
26. Coagulopathy induced by viperid snake venoms in a murine model: Comparison of standard coagulation tests and rotational thromboelastometry.
Rucavado A; Chacón M; Villalobos D; Argüello I; Campos M; Guerrero G; Méndez ML; Escalante T; Gutiérrez JM
Toxicon; 2022 Jul; 214():121-129. PubMed ID: 35644489
[TBL] [Abstract][Full Text] [Related]
27. Potential of herbal cocktail of medicinal plant extracts against 'big four' snake venoms from India.
Vasudev S; More VS; Ananthraju KS; More SS
J Ayurveda Integr Med; 2021; 12(3):458-464. PubMed ID: 34334287
[TBL] [Abstract][Full Text] [Related]
28. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
[TBL] [Abstract][Full Text] [Related]
29. Medical studies of poisonous land and sea snakes.
Vick JA
J Clin Pharmacol; 1994 Jun; 34(6):709-12. PubMed ID: 8083405
[TBL] [Abstract][Full Text] [Related]
30. Procoagulant snake venoms have differential effects in animal plasmas: Implications for antivenom testing in animal models.
Maduwage KP; Scorgie FE; Lincz LF; O'Leary MA; Isbister GK
Thromb Res; 2016 Jan; 137():174-177. PubMed ID: 26656242
[TBL] [Abstract][Full Text] [Related]
31. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.
Ratanabanangkoon K; Tan KY; Eursakun S; Tan CH; Simsiriwong P; Pamornsakda T; Wiriyarat W; Klinpayom C; Tan NH
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004565. PubMed ID: 27058956
[TBL] [Abstract][Full Text] [Related]
32. Anti-necrosis potential of polyphenols against snake venoms.
Leanpolchareanchai J; Pithayanukul P; Bavovada R
Immunopharmacol Immunotoxicol; 2009; 31(4):556-62. PubMed ID: 19874222
[TBL] [Abstract][Full Text] [Related]
33. Differential procoagulant effects of saw-scaled viper (Serpentes: Viperidae: Echis) snake venoms on human plasma and the narrow taxonomic ranges of antivenom efficacies.
Rogalski A; Soerensen C; Op den Brouw B; Lister C; Dashevsky D; Arbuckle K; Gloria A; Zdenek CN; Casewell NR; Gutiérrez JM; Wüster W; Ali SA; Masci P; Rowley P; Frank N; Fry BG
Toxicol Lett; 2017 Oct; 280():159-170. PubMed ID: 28847519
[TBL] [Abstract][Full Text] [Related]
34. Whole snake venoms: Cytotoxic, anti-metastatic and antiangiogenic properties.
Kerkkamp H; Bagowski C; Kool J; van Soolingen B; Vonk FJ; Vlecken D
Toxicon; 2018 Aug; 150():39-49. PubMed ID: 29763628
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
Cheng AC; Tsai IH
Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of anticoagulant and procoagulant properties of 28 snake venoms from families Elapidae, Viperidae, and purified Russell's viper venom-factor X activator (RVV-X).
Suntravat M; Nuchprayoon I; Pérez JC
Toxicon; 2010 Sep; 56(4):544-53. PubMed ID: 20677373
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulant activity of krait, coral snake, and cobra neurotoxic venoms with diverse proteomes are inhibited by carbon monoxide.
Nielsen VG; Frank N; Turchioe BJ
Blood Coagul Fibrinolysis; 2019 Dec; 30(8):379-384. PubMed ID: 31415248
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of the in vivo toxicity and pathophysiology of envenomation by three medically important Egyptian snake venoms.
Abd El-Aziz TM; Shoulkamy MI; Hegazy AM; Stockand JD; Mahmoud A; Mashaly AMA
Arch Toxicol; 2020 Jan; 94(1):335-344. PubMed ID: 31722041
[TBL] [Abstract][Full Text] [Related]
39. Prevention and improvement of clinical management of snakebite in Southern Asian countries: A proposed road map.
Mukherjee AK; Mackessy SP
Toxicon; 2021 Sep; 200():140-152. PubMed ID: 34280412
[TBL] [Abstract][Full Text] [Related]
40. ELISA for the detection of venoms from four medically important snakes of India.
Selvanayagam ZE; Gnanavendhan SG; Ganesh KA; Rajagopal D; Rao PV
Toxicon; 1999 May; 37(5):757-70. PubMed ID: 10219987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
